Schedule 13G ownership disclosure

Sarepta Therapeutics Inc

Security class unavailable · CUSIP: 803607100

Event date: 2017-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,576,970
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-074453
Form type
SC 13G
Filer
CAPITAL VENTURES INTERNATIONAL
CIK
CIK 1011712
Filed
Dec 21, 2017
Reporting period
Dec 11, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub